» Articles » PMID: 39193334

Polydatin Attenuated Neuropathic Pain and Motor Dysfunction Following Spinal Cord Injury in Rats by Employing Its Anti-inflammatory and Antioxidant Effects

Overview
Journal Front Pharmacol
Date 2024 Aug 28
PMID 39193334
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Considering the complex pathological mechanisms behind spinal cord injury (SCI) and the adverse effects of present non-approved drugs against SCI, new studies are needed to introduce novel multi-target active ingredients with higher efficacy and lower side effects. Polydatin (PLD) is a naturally occurring stilbenoid glucoside recognized for its antioxidative and anti-inflammatory properties. This study aimed to assess the effects of PLD on sensory-motor function following SCI in rats.

Methods: Following laminectomy and clip compression injury at the thoracic 8 (T8)-T9 level of the spinal cord, rats were randomly assigned to five groups: Sham, SCI, and three groups receiving different doses of PLD treatment (1, 2, and 3 mg/kg). Over 4 weeks, behavioral tests were done such as von Frey, acetone drop, hot plate, Basso-Beattie-Bresnahan, and inclined plane test. At the end of the study, changes in catalase and glutathione activity, nitrite level, activity of matrix metalloproteinase 2 (MMP2) and MMP9 as well as spinal tissue remyelination/neurogenesis, were evaluated.

Results: The results revealed that PLD treatment significantly improved the behavioral performance of the animals starting from the first week after SCI. Additionally, PLD increased catalase, and glutathione levels, and MMP2 activity while reduced serum nitrite levels and MMP9. These positive effects were accompanied by a reduction in the size of the lesion and preservation of neuronal count.

Conclusion: In conclusion, PLD showed neuroprotective effects in SCI rats by employing anti-inflammatory and antioxidant effects, through which improve sensory and motor function.

Citing Articles

Unveiling the effects of oligosaccharide liposome on neuropathic pain and motor dysfunction following spinal cord injury in rats: relevance to its antioxidative effects.

Ahmadpour Y, Bahrami G, Arkan E, Abbaszadeh F, Aghaz F, Fakhri S Front Pharmacol. 2025; 16:1533025.

PMID: 40028155 PMC: 11868053. DOI: 10.3389/fphar.2025.1533025.


Protective effects of polydatin amphiphilic chitosan nanocarriers against an aluminum chloride-induced model of Alzheimer's disease in rats: relevance to its anti-inflammatory and antioxidant effects.

Zarneshan S, Arkan E, Kiani A, Hosseini S, Abbaszadeh F, Fakhri S Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39786589 DOI: 10.1007/s00210-024-03696-2.


The Role of Phytochemicals in Managing Neuropathic Pain: How Much Progress Have We Made?.

Sic A, Manzar A, Knezevic N Nutrients. 2025; 16(24.

PMID: 39770963 PMC: 11678138. DOI: 10.3390/nu16244342.

References
1.
Chen G, Yang Z, Wen D, Guo J, Xiong Q, Li P . Polydatin has anti-inflammatory and antioxidant effects in LPS-induced macrophages and improves DSS-induced mice colitis. Immun Inflamm Dis. 2021; 9(3):959-970. PMC: 8342204. DOI: 10.1002/iid3.455. View

2.
Sun G, Chen Y, Zhou Z, Yang S, Zhong C, Li Z . A progressive compression model of thoracic spinal cord injury in mice: function assessment and pathological changes in spinal cord. Neural Regen Res. 2017; 12(8):1365-1374. PMC: 5607834. DOI: 10.4103/1673-5374.213693. View

3.
Xi P, Mao R, Wu S, Liu L, Cai C, Lu L . Using Network Pharmacology and Animal Experiment to Investigate the Therapeutic Mechanisms of Polydatin against Vincristine-Induced Neuropathic Pain. Mediators Inflamm. 2022; 2022:6010952. PMC: 9587674. DOI: 10.1155/2022/6010952. View

4.
Chen H, Wang D . Nitric oxide inhibits matrix metalloproteinase-2 expression via the induction of activating transcription factor 3 in endothelial cells. Mol Pharmacol. 2004; 65(5):1130-40. DOI: 10.1124/mol.65.5.1130. View

5.
Bheereddy P, Yerra V, Kalvala A, Sherkhane B, Kumar A . SIRT1 Activation by Polydatin Alleviates Oxidative Damage and Elevates Mitochondrial Biogenesis in Experimental Diabetic Neuropathy. Cell Mol Neurobiol. 2020; 41(7):1563-1577. PMC: 11448605. DOI: 10.1007/s10571-020-00923-1. View